ribavirin has been researched along with Iron Overload in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (75.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hörl, WH; Schmidt, A | 1 |
| Fujita, N; Hayashi, H; Iwasa, M; Kaito, M; Kobayashi, Y; Motonishi, S; Sugimoto, R; Takei, Y; Takeo, M; Tanaka, H; Tomosugi, N | 1 |
| Azim, J; McCurdy, H; Moseley, RH | 1 |
| Barbare, JC; Cadranel, JF; Capron, D; Cazier, A; Dumouchel, P; Jouannaud, V; Rochette, J | 1 |
| El-Zayadi, AR | 1 |
| Bielawski, KP; Izycka-Swieszewska, E; Romanowski, T; Sikorska, K; Stalke, P | 1 |
| Kalpaka, A; Klonizakis, P; Paschos, P; Pasvanti, C; Perifanis, V; Sinakos, E; Vlachaki, E | 1 |
| Goto, H; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Ishizu, Y; Itoh, A; Katano, Y; Nakano, I | 1 |
| Boulestin, A; Chatelut, E; Durand, D; Esposito, L; Izopet, J; Kamar, N; Rostaing, L; Sandres-Saune, K; Selves, J; Stébenet, M | 1 |
| Butensky, E; Foote, D; Harmatz, P; Pakbaz, Z; Vichinsky, EP; Walters, MC | 1 |
| Braga, EL; Freitas, LA; Lyra, AC; Lyra, LG; Moraes, CF; Souza, RM | 1 |
| Adachi, Y; Fujita, N; Hasegawa, K; Horiike, S; Iwasa, M; Kaito, M; Kawanishi, S; Kobayashi, Y; Ma, N; Sugimoto, R; Tanaka, H | 1 |
| Bassett, ML | 1 |
| Adachi, Y; Araki, J; Fujita, N; Horiike, S; Iwasa, M; Kaito, M; Kobayashi, Y; Mifuji, R; Sugimoto, R; Tanaka, H; Urawa, N; Yamamoto, M | 1 |
| Kasahara, A | 1 |
| Ashton-Prolla, P; Cheinquer, H; Cheinquer, N; Coelho-Borges, S; Krug, L | 1 |
1 review(s) available for ribavirin and Iron Overload
| Article | Year |
|---|---|
Treatment strategies for chronic hepatitis C virus infection.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Iron Overload; Liver Neoplasms; Ribavirin; Treatment Outcome; Ursodeoxycholic Acid | 2000 |
3 trial(s) available for ribavirin and Iron Overload
| Article | Year |
|---|---|
The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Case-Control Studies; Demography; Female; Hemochromatosis Protein; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon alpha-2; Interferon-alpha; Iron; Iron Overload; Liver Cirrhosis; Male; Membrane Proteins; Middle Aged; Mutation; Poland; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; Young Adult | 2010 |
Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience.
Topics: Adult; Antiviral Agents; beta-Thalassemia; Chelation Therapy; Drug Therapy, Combination; Female; Greece; Hepatitis C, Chronic; Homozygote; Humans; Interferon alpha-2; Interferon-alpha; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Transfusion Reaction; Treatment Outcome | 2011 |
Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
Topics: Adult; Aged; Alcohol Drinking; Antiviral Agents; Disease Progression; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Iron; Iron Overload; Liver; Male; Middle Aged; Platelet Count; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Sex Factors; Transaminases; Treatment Outcome | 2007 |
12 other study(ies) available for ribavirin and Iron Overload
| Article | Year |
|---|---|
Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.
Topics: Adult; Animals; Antimicrobial Cationic Peptides; Antiviral Agents; Epidermal Growth Factor; Female; Hepacivirus; Hepatitis C, Chronic; Hepatocyte Growth Factor; Hepcidins; Humans; Interferon-alpha; Iron; Iron Overload; Liver Cirrhosis; Male; Middle Aged; Phlebotomy; Renal Insufficiency, Chronic; Ribavirin; Virus Replication | 2014 |
Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.
Topics: Adult; Aged; Antimicrobial Cationic Peptides; Antiviral Agents; Case-Control Studies; Drug Therapy, Combination; Female; Ferritins; Hepatitis C, Chronic; Hepcidins; Humans; Interferon alpha-2; Interferon-alpha; Iron Overload; Liver; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Messenger | 2008 |
Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C.
Topics: Anemia, Hemolytic; Antiviral Agents; Drug Therapy, Combination; Hemochromatosis; Hemochromatosis Protein; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon alpha-2; Interferon-alpha; Iron Overload; Male; Membrane Proteins; Middle Aged; Mutation; Phlebotomy; Polyethylene Glycols; Porphyria Cutanea Tarda; Recombinant Proteins; Ribavirin | 2008 |
Marked iron overload related to ribavirin and iron sulfate treatment in a patient with active viral C cirrhosis.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Ferritins; Ferrous Compounds; Hepatitis C, Chronic; Humans; Iron Overload; Middle Aged; Ribavirin | 2009 |
Hepatitis C comorbidities affecting the course and response to therapy.
Topics: Alcoholism; Antiviral Agents; Comorbidity; Gastroenterology; Hepatitis C; Humans; Interferons; Iron Overload; Polyethylene Glycols; Ribavirin; Schistosomiasis; Smoking; Treatment Outcome | 2009 |
Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hemochromatosis Protein; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon alpha-2; Interferon-alpha; Iron Overload; Male; Membrane Proteins; Middle Aged; Mutation; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load | 2012 |
Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
Topics: Adult; Aged; Anemia, Hemolytic; Antiviral Agents; Cytokines; Female; Hepatitis C, Chronic; Humans; Iron; Iron Overload; Kidney Transplantation; Liver; Liver Cirrhosis; Male; Middle Aged; Postoperative Complications; Ribavirin; Transferrin | 2005 |
Treatment of hepatitis C virus infection in thalassemia.
Topics: Adolescent; Adult; Antiviral Agents; Biopsy, Needle; Bone Marrow Transplantation; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Iron; Iron Overload; Liver; Magnetic Resonance Imaging; Male; Mass Spectrometry; Polyethylene Glycols; Ribavirin; Thalassemia; Transfusion Reaction; Treatment Outcome; Viremia | 2005 |
Effect of iron overload on the severity of liver histologic alterations and on the response to interferon and ribavirin therapy of patients with hepatitis C infection.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Iron Overload; Male; Middle Aged; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; Severity of Illness Index | 2006 |
Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Alanine Transaminase; Antimicrobial Cationic Peptides; Antiviral Agents; Aspartate Aminotransferases; Deoxyguanosine; DNA Adducts; DNA Damage; Drug Therapy, Combination; Female; Ferritins; Hepatitis C, Chronic; Hepcidins; Humans; Interferons; Iron Overload; Liver; Male; Middle Aged; Oxidative Stress; Ribavirin | 2007 |
Iron and hepatitis C: beginning to make sense.
Topics: Alcohol Drinking; Antiviral Agents; Disease Progression; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Iron; Iron Overload; Liver; Phlebotomy; Platelet Count; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Sex Factors; Transaminases; Treatment Failure; Treatment Outcome | 2007 |
HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload.
Topics: Adult; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Hemochromatosis Protein; Hepacivirus; Hepatitis C, Chronic; Histocompatibility Antigens Class I; HLA Antigens; Humans; Interferons; Iron Overload; Male; Membrane Proteins; Middle Aged; Mutation; Ribavirin | 2002 |